GlobeNewswire Inc. · Mar 12, 2024
ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (Nasdaq: ALTUU, ALTU, ALTUW) (the “Company”), today announced that it will redeem all of its outstanding shares of Class A common stock initially issued as part of the units sold in its initial public offering (the “Public Shares”), effective as of March 12, 2024, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. The Company further announced that it will not proceed with the previously-announced hearing before a hearings panel of the Nasdaq Stock Market (“Nasdaq”) with respect to Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Accordingly, the Company’s securities will be delisted from Nasdaq.
GlobeNewswire Inc. · Feb 7, 2024
ATLANTA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (Nasdaq: ALTUU, ALTU, ALTUW) (“Altitude”), announced today that its board of directors (the “Board”) has extended the date by which Altitude must consummate an initial business combination (the “Deadline Date”) for an additional month, from February 11, 2024 to March 11, 2024.
GlobeNewswire Inc. · Jan 11, 2024
ATLANTA, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (Nasdaq: ALTUU, ALTU, ALTUW) (“Altitude”), announced today that its board of directors (the “Board”) has extended the date by which Altitude must consummate an initial business combination (the “Deadline Date”) for an additional month, from January 11, 2024 to February 11, 2024.
GlobeNewswire Inc. · Aug 14, 2023
ATLANTA and PALO ALTO, Calif. and TUCSON, Ariz., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (“Altitude”) (Nasdaq: ALTU) and Picard Medical, Inc. (“Picard”), the parent company of SynCardia Systems, LLC (“SynCardia”), the global leader in mechanical heart replacement technology, today announced the filing of a preliminary proxy statement on Schedule 14A with the U.S. Securities and Exchange Commission (“SEC”), and in connection with their previously announced business combination. Picard also announced the completion of the audit of its financial statements as of and for the year ended December 31, 2022.
